文献速递咽喉与嗓音

地塞米松对声带的急性体外与体内效应:一项先导研究

Acute In Vitro and In Vivo Effects of Dexamethasone in the Vocal Folds: a Pilot Study.
PubMed 文献 · Laryngoscope · 2022-11-01

该先导研究采用体外与体内模型探究地塞米松对声带上皮、甲杓肌及甲杓肌来源成肌细胞的影响。体外实验显示地塞米松增加甲杓肌成肌细胞中MuRF-1基因表达;体内实验15只兔随机分三组,注射后7天未观察到萎缩相关基因表达、肌纤维横截面积或上皮厚度的改变。作者认为体内诱导萎缩可能需要重复注射地塞米松。

要点

  • 地塞米松增加甲杓肌成肌细胞中MuRF-1基因表达。
  • 体内注射地塞米松未改变萎缩相关基因表达、肌纤维横截面积或上皮厚度。
  • 作者认为体内诱导萎缩可能需要重复注射地塞米松。

核心结论

  • 地塞米松增加甲杓肌成肌细胞中萎缩相关基因表达,为糖皮质激素诱导的萎缩基因转录提供基础见解。
  • 作者认为体内诱导萎缩可能需要重复注射地塞米松。

研究设计与样本

  • 体外为临床前研究,甲杓肌成肌细胞分离自一只雌性Sprague-Dawley大鼠并以1 μM地塞米松处理24小时。
  • 体内将15只新西兰白兔随机分为三组:双侧声带内注射40 μL地塞米松(10 mg/ml;n=5)、等体积生理盐水(n=5)和未处理对照(n=5),注射后7天取材。

主要发现

  • 地塞米松增加甲杓肌成肌细胞中MuRF-1基因表达。
  • 体内地塞米松注射未改变萎缩相关基因表达、甲杓肌纤维横截面积或上皮厚度。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: Glucocorticoids (GC)s are commonly employed to treat vocal fold (VF) pathologies. However, VF atrophy has been associated with intracordal GC injections. Dexamethasone-induced skeletal muscle atrophy is well-documented in other tissues and believed to be mediated by increased muscle proteolysis via upregulation of Muscle Ring Finger (MuRF)-1 and Atrogin-1. Mechanisms of dexamethasone-mediated VF atrophy have not been described. This pilot study employed in vitro and in vivo models to investigate the effects of dexamethasone on VF epithelium, thyroarytenoid (TA) muscle, and TA-derived myoblasts. We hypothesized that dexamethasone will increase atrophy-associated gene expression in TA muscle and myoblasts and decrease TA muscle fiber size and epithelial thickness. STUDY DESIGN: In vitro, pre-clinical. METHODS: TA myoblasts were isolated from a female Sprague-Dawley rat and treated with 1 μM dexamethasone for 24-h. In vivo, 15 New Zealand white rabbits were randomly assigned to three treatment groups: (1) bilateral intracordal injection of 40 μL dexamethasone (10 mg/ml; n = 5), (2) volume-matched saline (n = 5), and (3) untreated controls (n = 5). Larynges were harvested 7-days post-injection. Across in vivo and in vitro experimentation, MuRF-1 and Atrogin-1 mRNA expression were measured via RT-qPCR. TA muscle fiber cross-sectional area (CSA) and epithelial thickness were also quantified in vivo. RESULTS: Dexamethasone increased MuRF-1 gene expression in TA myoblasts. Dexamethasone injection, however, did not alter atrophy-associated gene expression, TA CSA, or epithelial thickness in vivo. CONCLUSION: Dexamethasone increased atrogene expression in TA myoblasts, providing foundational insight into GC induced atrophic gene transcription. Repeated dexamethasone injections may be required to elicit atrophy in vivo. LEVEL OF EVIDENCE: NA Laryngoscope, 133:2264-2270, 2023.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Gartling G, Nakamura R, Sayce L, et al. Acute In Vitro and In Vivo Effects of Dexamethasone in the Vocal Folds: a Pilot Study. Laryngoscope. 2022. PMID: 36317801. doi:10.1002/lary.30461

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。